OHE Expert Profile
Phill O’Neill
Information Specialist
Phill has over 25 years’ experience in the use of pharmaceutical industry data and information. His research interests include the economics of the pharmaceutical market, the productivity, and outputs of NICE, and benchmarking industry performance. Phill was the lead analyst for several industry and Government economic benchmarking initiatives including the Pharmaceutical Industry Competitiveness Taskforce (PICTF) Indicators, Scottish Market Understanding Initiative, and G10 Competitiveness Indicators for the EU. Phill is a previous chair of the EFPIA Statistics Group.
Latest Publications
![Dementia in the UK: Estimating the Potential Future Impact and Return on Research Investment](https://www.ohe.org/wp-content/uploads/2023/07/image-option-1-scaled-e1688978108372.jpg)
Dementia in the UK: Estimating the Potential Future Impact and Return on Research Investment
![NICE enough? Do NICE’s Decision Outcomes Impact International HTA Decision-making?](https://www.ohe.org/wp-content/uploads/2023/09/andrew-butler-aUu8tZFNgfM-unsplash-scaled.jpg)
NICE enough? Do NICE’s Decision Outcomes Impact International HTA Decision-making?
![Realising the Broader Value of Vaccines in the UK](https://www.ohe.org/wp-content/uploads/2020/07/Value-of-Vaccines-150x150.png)
![NICE ‘Optimised’ Decisions: What is the Recommended Level of Patient Access?](https://www.ohe.org/wp-content/uploads/2020/07/Cover-Optimised-Decisions_0.png)
NICE ‘Optimised’ Decisions: What is the Recommended Level of Patient Access?
![Mesurement of medicine PPRS cover page](https://www.ohe.org/wp-content/uploads/2018/08/Mesurement-of-medicine-PPRS-cover-page.jpg)
Measurement of Medicines Expenditure in the Context of the 2014-18 PPRS
![Phill O’Neill](https://www.ohe.org/wp-content/uploads/2014/05/Phill-3-scaled-1.jpg)
Similar Experts